CD200 RECEPTOR ANTAGONIST BINDING MOLECULES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20220396619A1
SERIAL NO

17774214

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antagonist polypeptide molecules that bind to human CD200 receptor, and are useful for treating solid tumors, alone and in combination with chemotherapy, ionizing radiation, an antitumor agent and/or an immuno-oncology agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELI LILLY AND COMPANYLILLY CORPORATE CENTER PATENT DIVISION INDIANAPOLIS IN 46285

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BELL-MCGUINN, Katherine Marie Zionsville, US 1 0
DEMAREST, Stephen John San Diego, US 8 15
DRISCOLL, Kyla Elizabeth Rutherford, US 4 1
HOLMGAARD, Rikke Baek West New York, US 5 0
RUSSELL, Anna Marie San Diego, US 1 0
SLEIMAN, HAIDAR Jaafar Nassar Medfield, US 1 0
WITCHER, Derrick Ryan Fishers, US 31 103

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation